PAUL F TRUEX
CIK 1120362 · Executive Chaiman · last filed 2022-06-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.2K
Companies
4
Total Filings
58
Lifetime Open-Market Net
-$987.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MIST | Director | 8,016 | $1.27 | $10.2K | $28.0K | 4 | 2022-06-01 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 8 | 2021-01-28 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Executive Chaiman | 21,801 | — | — | -$1.03M | 39 | 2018-01-09 |
| Trius Therapeutics Inc (TSRX) Delisted | Director | 13,270 | — | — | $17.1K | 6 | 2013-05-23 |
Recent Filings · Page 4 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-07-02 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Buy (P) | +20,000 | $15.2K | EDGAR |
| 2012-05-24 | Trius Therapeutics Inc (TSRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-04-03 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-02-17 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −15,000 | -$117.6K | EDGAR |
| 2012-02-06 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Grant (A) | +37,984 | $0 | EDGAR |
| 2012-02-02 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Mixed | +13,000 | $5.2K | EDGAR |
| 2012-01-19 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −15,000 | -$101.2K | EDGAR |
| 2011-12-16 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −15,000 | -$95.1K | EDGAR |
| 2011-11-17 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Mixed | −30,000 | -$208.7K | EDGAR |
| 2011-10-25 | Anthera Pharmaceuticals Inc (ANTH) Delisted | Sell (S) | −23,235 | -$145.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.